According to Reuters, Eli Lilly expects FDA approval for its oral obesity drug in March 2026
In one of two recently published studies in JAMA Neurology , Allie Seminer , MSc , and Alfredi Mulihano , undergraduate students in the School of Medicine at the University of Galway in Ireland, and colleagues found that GLP-1 receptor agonists significantly reduced the risk for all-cause dementia, but SGLT2 inhibitors did not
Resistance Performance: Each FitS36 capsule provides 100 mg caffeine, supporting endurance capacity during physical activities
The kind that cant be topped up with a salad or a smoothie
It blocks the action of the DPP-4 enzyme
I tried prescription injections for a few months and lost 22 pounds, but the constant nausea and $900/month cost just wasnt worth it